Eurofins Genomics India Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.23 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 M
- Revenue Growth -5.73%
- Profit Growth -250.65%
- Ebitda -43.56%
- Net Worth 37.51%
- Total Assets 61.14%
About Eurofins Genomics India
Eurofins Genomics India Private Limited (EGIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 April 2004 and has a history of 20 years and ten months. Its registered office is in Bangalore, Karnataka, India.
The Corporate was formerly known as Mwg-Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.23 Cr.
The company currently has active open charges totaling ₹2.70 M.
Neeraj Garg and Sanjeev Kamate serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85195KA2004PTC033689
- Company No.
033689
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Eurofins Genomics India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kamate  | Managing Director | 05-Nov-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Garg | Director | 27-Feb-2019 | Current |
Financial Performance of Eurofins Genomics India.
Eurofins Genomics India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.73% decrease. The company also saw a substantial fall in profitability, with a 250.65% decrease in profit. The company's net worth Soared by an impressive increase of 37.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurofins Genomics India?
In 2023, Eurofins Genomics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eurofins Advinus Biopharma Services India Private LimitedNeeraj Garg is a mutual person
- Eurofins Advinus Discovery Services Private Limited
Neeraj Garg is a mutual person
- Eurofins Peenya Resources Private Limited
Neeraj Garg is a mutual person
Eurofins Clinical Diagnostics Bangalore Private LimitedNeeraj Garg and Sanjeev Kamate are mutual person
Adgyl Lifesciences Private LimitedNeeraj Garg is a mutual person
Eurofins Amar Immunodiagnostics Private LimitedNeeraj Garg is a mutual person
Charges (Loans)
₹0.27 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Axis Bank Limited | ₹2.70 M | Open |
How Many Employees Work at Eurofins Genomics India?
Eurofins Genomics India has a workforce of 338 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurofins Genomics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Genomics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
